Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

STAAR Surgical Company

STAA
Current price
18.03 USD +0.29 USD (+1.63%)
Last closed 17.40 USD
ISIN US8523123052
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 881 938 112 USD
Yield for 12 month -61.99 %
1Y
3Y
5Y
10Y
15Y
STAA
21.11.2021 - 28.11.2021

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Address: 25510 Commercentre Drive, Lake Forest, CA, United States, 92630

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.50 USD

P/E ratio

Dividend Yield

Current Year

+313 901 000 USD

Last Year

+322 415 000 USD

Current Quarter

+48 950 000 USD

Last Quarter

+88 590 000 USD

Current Year

+239 582 000 USD

Last Year

+252 651 000 USD

Current Quarter

+31 648 000 USD

Last Quarter

+68 487 000 USD

Key Figures STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 458 000 USD
Operating Margin TTM -56.89 %
Price to Earnings
Return On Assets TTM -1.55 %
PEG Ratio -4.89
Return On Equity TTM -5.16 %
Wall Street Target Price 18.50 USD
Revenue TTM 313 900 992 USD
Book Value 8.06 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -35.80 %
Dividend Yield
Gross Profit TTM 239 582 000 USD
Earnings per share -0.41 USD
Diluted Eps TTM -0.41 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY 101.80 %
Profit Margin -6.44 %

Dividend Analytics STAA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:2
Payout Ratio TTM
Last Split Date 18.05.1992

Stock Valuation STAA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 625.00
Enterprise Value Revenue 2.12
Price Sales TTM 2.81
Enterprise Value EBITDA 42.84
Price Book MRQ 2.16

Financials STAA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators STAA

For 52 weeks

13.50 USD 49.86 USD
50 Day MA 17.19 USD
Shares Short Prior Month 4 434 674
200 Day MA 27.39 USD
Short Ratio 4.81
Shares Short 5 211 952
Short Percent 21.04 %